Delving into the Latest Updates on Beaufour Ipsen Pharma SAS with Synapse

概览

关联

1

项与 Beaufour Ipsen Pharma SAS 相关的药物

BN-80933

靶点

Free radicals x NOSs

作用机制

自由基抑制剂 [+1]

在研机构-

原研机构

Beaufour Ipsen Pharma SAS

在研适应症-

非在研适应症

脑缺血

最高研发阶段终止

首次获批国家/地区-

首次获批日期-

2

项与 Beaufour Ipsen Pharma SAS 相关的临床试验

EUCTR2004-001845-13-CZ

/ Not yet recruitingN/A

A phase II, multicentre, multinational, prospective, randomised, double-blind, placebo controlled study assessing the efficacy and safety of a single application of three doses of Dysport in patients with upper back myofascial pain syndrome (MPS)

开始日期2005-02-11

申办/合作机构

Beaufour Ipsen Pharma SAS

EUCTR2004-001164-41-SE

/ Not yet recruitingN/A

AN EXPLORATORY, OPEN, TWO-ARM, MATCH-CONTROL, RANDOMISED AND STRATIFIED PILOT PHASE II STUDY ASSESSING THE PREVENTION OF THE ADVERSE EFFECTS OF LONG-TERM HIGH-DOSE GLUCOCORTICOID THERAPY BY GROWTH HORMONE (NutropinAqTM) ADMINISTERED BY SUB-CUTANEOUS ROUTE IN CHILDREN WITH CHRONIC DISEASE

开始日期2004-11-25

申办/合作机构

Beaufour Ipsen Pharma SAS

100 项与 Beaufour Ipsen Pharma SAS 相关的临床结果

登录后查看更多信息

0 项与 Beaufour Ipsen Pharma SAS 相关的专利（医药）

登录后查看更多信息

1

项与 Beaufour Ipsen Pharma SAS 相关的文献（医药）

Current Topics in Nutraceutical Research

From clinical observations to molecular biology: Ginkgo biloba extract EGB 761, a success for reverse pharmacology

作者: Christen, Yves

A review.Ginkgo biloba extract, EGb 761, is a drug used to treat cerebral insufficiency and other brain disorders (including dementia), neurosensory deficiencies and peripheral circulatory disturbances.First marketed in 1975, it has been subjected to numerous clin., pharmacol., and mol. studies.The synthesis presented here demonstrates the consistency of the data about its multiple effects in the treatment of age-associated cognitive disorders.Current research on EGb 761 is not limited to its effects in humans.Although the development of drugs normally proceeds from basic research to the study of clin. effects, EGb 761 provides an example of the reverse procedure: its clin. applications have been studied before the mol. mechanisms involved were investigated.I propose to call this mode of research "reverse pharmacol.", by analogy with "reverse genetics", and I show how it applies to the study of the cognitive and anti-dementia effects of EGb 761.

100 项与 Beaufour Ipsen Pharma SAS 相关的药物交易

登录后查看更多信息

100 项与 Beaufour Ipsen Pharma SAS 相关的转化医学

登录后查看更多信息